APOL1 nephropathy: from gene to mechanisms of kidney injury.
about
Opportunities and Challenges of Genotyping Patients With Nephrotic Syndrome in the Genomic EraInsights into kidney diseases from genome-wide association studies.Screening of Living Kidney Donors for Genetic Diseases Using a Comprehensive Genetic Testing Strategy.APOL1 renal risk variants have contrasting resistance and susceptibility associations with African trypanosomiasis.Genetics of Lupus Nephritis: Clinical Implications.Thrombotic microangiopathy: expanding genetic, clinical and therapeutic spectra and the need for worldwide implementation of recent advancesAPOL1 Genotype and Kidney Transplantation Outcomes From Deceased African American Donors.Analytical Validation of a Personalized Medicine APOL1 Genotyping Assay for Nondiabetic Chronic Kidney Disease Risk Assessment.Impact of APOL1 polymorphism and IL-1β priming in the entry and persistence of HIV-1 in human podocytes.The Evaluation and Therapeutic Management of Hypertension in the Transplant Patient.Genetic predictors of long-term graft function in kidney and pancreas transplant patients.A null variant in the apolipoprotein L3 gene is associated with non-diabetic nephropathy.APOL1 Gene Kidney Risk Variants and Cardiovascular Disease: Getting to the Heart of the Matter.Viral-Associated GN: Hepatitis C and HIV.New Insights into Podocyte Biology in Glomerular Health and Disease.An investigation of APOL1 risk genotypes and preterm birth in African American population cohorts.APOL1-associated glomerular disease among African-American children: a collaboration of the Chronic Kidney Disease in Children (CKiD) and Nephrotic Syndrome Study Network (NEPTUNE) cohorts.Race, APOL1 Risk, and eGFR Decline in the General Population.APOL1 renal-risk variants do not associate with incident cardiovascular disease or mortality in the Systolic Blood Pressure Intervention Trial.Late Reoccurrence of Collapsing FSGS After Transplantation of a Living-Related Kidney Bearing APOL 1 Risk Variants Without Disease Evident in Donor Supports the Second Hit Hypothesis.APOL1 renal-risk genotypes associate with longer hemodialysis survival in prevalent nondiabetic African American patients with end-stage renal disease.Hemostatic Factors, APOL1, and ESRD Risk: Another Piece of the Puzzle?Beyond APOL1: Genetic Inroads into Understanding Population Disparities in Diabetic Kidney Disease.Evolutionary Nephrology.Does copy number variation of APOL1 gene affect the susceptibility to focal segmental glomerulosclerosis?APOL1-Associated End-Stage Renal Disease in a Living Kidney Transplant Donor.APOL1-Mediated Cell Injury Involves Disruption of Conserved Trafficking Processes.Genomic medicine for kidney disease.Hypertension in African Americans.Apolipoprotein L1 Gene Effects on Kidney Transplantation.Genetics of human lupus nephritis.HIV-associated nephropathy: links, risks and management.
P2860
Q26799197-3CF5D3F5-81C4-4AC6-A751-D32811CFDDB8Q30248678-5394DE47-B87F-4741-96A5-9D13DB06E6ADQ30362814-4FEAEA64-7192-4824-BF7B-B079FCCB6B32Q33866444-B34030D6-8013-46BF-8161-101AD147AE7FQ36300008-FD31D194-5758-4579-8A62-D8FDD31B2546Q36306802-E4B704F1-79D3-495E-B39D-6BE7150E0BE9Q36385113-FC203AC9-91F0-46F7-A5CE-785768C579DBQ36753746-AF2F7EDE-AF1E-4B94-8740-260049451D7FQ37233039-AA41C014-E669-420B-AA45-41924A41D81AQ38585232-2AAA758E-93E8-4AC7-8730-342D639129B3Q38767421-07EB2F15-90E1-4C33-9C69-67119AA88831Q38878740-6F910969-8CA6-4121-8C40-91381DDF46F5Q39112267-EF98DAD9-475D-43BA-A325-82FC433E3917Q39232052-7F86A390-33E2-49AA-9ABE-A35D8836DF9AQ39238888-F2D484F1-4172-4651-AE22-3F13D329BB61Q39379366-745CA2E9-2EF3-4BB8-B3CC-7A16D19C8B49Q40749201-EB43D75B-5843-47A2-B517-4011CBC9513BQ40860089-CCCE860E-4961-4D50-A3FA-38E8D104106DQ41129046-786EB323-6C7C-4642-A4FC-B2E68FBFD441Q41217150-E04B7B60-0105-426B-8243-1CA20D0D29AAQ42417122-97C20319-1DE7-423E-B59D-989B5A1E83B9Q42569055-7A7114F9-D8C5-45EE-A7EC-D6534E01C8D3Q42743345-D9BD1559-F6D7-4290-97D3-1A0486B06F7CQ43573882-03168811-46A3-4974-A709-10612AEB7A36Q46321479-8C929980-6A94-42E2-9216-6528A9F61176Q46354781-E1C218FC-8425-42B2-9D1E-2E93F728CB1EQ46457437-C55BEAD6-10C0-44EA-A6CA-361C326B0F3FQ47200436-EDC1F546-2547-4E3C-95B8-6B976EC0EDF0Q47635539-3221DAEE-0218-4814-827E-E97882382B28Q47644189-31D00A97-662C-4CC9-B858-8301743570D9Q52897553-6F5145C1-9C35-4393-96C4-76BF27844A8AQ55367471-E8529FFD-05A5-45DF-94AC-A9F9A551C58E
P2860
APOL1 nephropathy: from gene to mechanisms of kidney injury.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
APOL1 nephropathy: from gene to mechanisms of kidney injury.
@en
type
label
APOL1 nephropathy: from gene to mechanisms of kidney injury.
@en
prefLabel
APOL1 nephropathy: from gene to mechanisms of kidney injury.
@en
P2093
P2860
P356
P1476
APOL1 nephropathy: from gene to mechanisms of kidney injury.
@en
P2093
Etty Kruzel-Davila
Karl Skorecki
Sharon Aviram
Walter G Wasser
P2860
P304
P356
10.1093/NDT/GFU391
P407
P577
2015-01-05T00:00:00Z